Overview

Perioperative Glucose Monitoring and Treatment to Reduce Risk of Surgical Site Infections and Complications

Status:
ENROLLING_BY_INVITATION
Trial end date:
2025-01-31
Target enrollment:
Participant gender:
Summary
This study is to determine if glucose monitoring and treatment in surgical procedures over 2 hours help to decrease the surgical site infection risk and reduce postoperative complications. The study uses a preoperative HgBA1C to place patient into a sliding scale insulin category to be used only if the patient has a blood sugar over 150mg/dL during surgery. This is consistent with the CDC recommendation to keep perioperative glucose below 200 mg/dL in surgical patients. The protocol continues for at least 48 hours to treat stress hyperglycemia in non-diabetic patients, and to closely monitor \& treat glucose levels in diabetic patients.
Phase:
NA
Details
Lead Sponsor:
St. Peter's Hospital, Albany, NY
Treatments:
Insulin Lispro